vs
Side-by-side financial comparison of HARROW, INC. (HROW) and RE/MAX Holdings, Inc. (RMAX). Click either name above to swap in a different company.
HARROW, INC. is the larger business by last-quarter revenue ($89.1M vs $71.1M, roughly 1.3× RE/MAX Holdings, Inc.). HARROW, INC. runs the higher net margin — 7.4% vs 2.0%, a 5.4% gap on every dollar of revenue. On growth, HARROW, INC. posted the faster year-over-year revenue change (33.3% vs -1.8%). RE/MAX Holdings, Inc. produced more free cash flow last quarter ($33.5M vs $8.1M). Over the past eight quarters, HARROW, INC.'s revenue compounded faster (60.5% CAGR vs -4.7%).
Harrow Health, Inc., formerly known as Imprimis Pharmaceuticals, is a publicly traded pharmaceutical company based in Nashville, Tennessee.
RE/MAX is an international real estate franchise operating in over 100 countries and territories that, in 2015, had over 100,000 agents in 6,800 offices.
HROW vs RMAX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $89.1M | $71.1M |
| Net Profit | $6.6M | $1.4M |
| Gross Margin | 79.3% | — |
| Operating Margin | 17.5% | 13.1% |
| Net Margin | 7.4% | 2.0% |
| Revenue YoY | 33.3% | -1.8% |
| Net Profit YoY | -2.2% | -75.2% |
| EPS (diluted) | $0.20 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $89.1M | $71.1M | ||
| Q3 25 | $71.6M | $73.2M | ||
| Q2 25 | $63.7M | $72.8M | ||
| Q1 25 | $47.8M | $74.5M | ||
| Q4 24 | $66.8M | $72.5M | ||
| Q3 24 | $49.3M | $78.5M | ||
| Q2 24 | $48.9M | $78.5M | ||
| Q1 24 | $34.6M | $78.3M |
| Q4 25 | $6.6M | $1.4M | ||
| Q3 25 | $1.0M | $4.0M | ||
| Q2 25 | $5.0M | $4.7M | ||
| Q1 25 | $-17.8M | $-2.0M | ||
| Q4 24 | $6.8M | $5.8M | ||
| Q3 24 | $-4.2M | $966.0K | ||
| Q2 24 | $-6.5M | $3.7M | ||
| Q1 24 | $-13.6M | $-3.4M |
| Q4 25 | 79.3% | — | ||
| Q3 25 | 75.3% | — | ||
| Q2 25 | 74.5% | — | ||
| Q1 25 | 67.5% | — | ||
| Q4 24 | 78.8% | — | ||
| Q3 24 | 75.6% | — | ||
| Q2 24 | 74.4% | — | ||
| Q1 24 | 69.5% | — |
| Q4 25 | 17.5% | 13.1% | ||
| Q3 25 | 20.6% | 25.0% | ||
| Q2 25 | 17.9% | 19.3% | ||
| Q1 25 | -23.5% | 7.2% | ||
| Q4 24 | 19.3% | 5.9% | ||
| Q3 24 | 2.7% | 19.4% | ||
| Q2 24 | 3.1% | 20.6% | ||
| Q1 24 | -20.0% | 5.8% |
| Q4 25 | 7.4% | 2.0% | ||
| Q3 25 | 1.4% | 5.4% | ||
| Q2 25 | 7.8% | 6.4% | ||
| Q1 25 | -37.2% | -2.6% | ||
| Q4 24 | 10.1% | 8.0% | ||
| Q3 24 | -8.6% | 1.2% | ||
| Q2 24 | -13.2% | 4.7% | ||
| Q1 24 | -39.2% | -4.3% |
| Q4 25 | $0.20 | — | ||
| Q3 25 | $0.03 | — | ||
| Q2 25 | $0.13 | — | ||
| Q1 25 | $-0.50 | — | ||
| Q4 24 | $0.19 | — | ||
| Q3 24 | $-0.12 | — | ||
| Q2 24 | $-0.18 | — | ||
| Q1 24 | $-0.38 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $72.9M | $118.7M |
| Total DebtLower is stronger | $250.0M | $432.2M |
| Stockholders' EquityBook value | $52.4M | $452.4M |
| Total Assets | $399.5M | $582.5M |
| Debt / EquityLower = less leverage | 4.77× | 0.96× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $72.9M | $118.7M | ||
| Q3 25 | $74.3M | $107.5M | ||
| Q2 25 | $53.0M | $94.3M | ||
| Q1 25 | $66.7M | $89.1M | ||
| Q4 24 | $47.2M | $96.6M | ||
| Q3 24 | $72.6M | $83.8M | ||
| Q2 24 | $71.0M | $66.1M | ||
| Q1 24 | $76.0M | $82.1M |
| Q4 25 | $250.0M | $432.2M | ||
| Q3 25 | $347.2M | $433.3M | ||
| Q2 25 | $250.6M | $434.4M | ||
| Q1 25 | $256.9M | $435.3M | ||
| Q4 24 | $262.7M | $436.2M | ||
| Q3 24 | $230.7M | $437.2M | ||
| Q2 24 | $236.3M | $438.1M | ||
| Q1 24 | $243.4M | $439.0M |
| Q4 25 | $52.4M | $452.4M | ||
| Q3 25 | $47.0M | $448.1M | ||
| Q2 25 | $49.7M | $442.4M | ||
| Q1 25 | $56.5M | $433.5M | ||
| Q4 24 | $69.7M | $429.5M | ||
| Q3 24 | $58.0M | $423.1M | ||
| Q2 24 | $58.5M | $418.4M | ||
| Q1 24 | $60.6M | $412.0M |
| Q4 25 | $399.5M | $582.5M | ||
| Q3 25 | $363.1M | $582.2M | ||
| Q2 25 | $345.0M | $574.8M | ||
| Q1 25 | $364.2M | $571.4M | ||
| Q4 24 | $389.0M | $581.6M | ||
| Q3 24 | $351.5M | $578.6M | ||
| Q2 24 | $306.6M | $571.4M | ||
| Q1 24 | $295.5M | $566.7M |
| Q4 25 | 4.77× | 0.96× | ||
| Q3 25 | 7.39× | 0.97× | ||
| Q2 25 | 5.05× | 0.98× | ||
| Q1 25 | 4.55× | 1.00× | ||
| Q4 24 | 3.77× | 1.02× | ||
| Q3 24 | 3.98× | 1.03× | ||
| Q2 24 | 4.04× | 1.05× | ||
| Q1 24 | 4.02× | 1.07× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $8.4M | $40.9M |
| Free Cash FlowOCF − Capex | $8.1M | $33.5M |
| FCF MarginFCF / Revenue | 9.1% | 47.1% |
| Capex IntensityCapex / Revenue | 0.4% | 10.4% |
| Cash ConversionOCF / Net Profit | 1.27× | 28.39× |
| TTM Free Cash FlowTrailing 4 quarters | $43.0M | $56.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.4M | $40.9M | ||
| Q3 25 | $16.6M | $17.7M | ||
| Q2 25 | $-803.0K | $4.6M | ||
| Q1 25 | $19.7M | $5.7M | ||
| Q4 24 | $-17.8M | $59.7M | ||
| Q3 24 | $3.0M | $17.6M | ||
| Q2 24 | $-2.7M | $15.9M | ||
| Q1 24 | $-4.6M | $9.4M |
| Q4 25 | $8.1M | $33.5M | ||
| Q3 25 | $16.4M | $16.4M | ||
| Q2 25 | $-969.0K | $2.9M | ||
| Q1 25 | $19.5M | $4.0M | ||
| Q4 24 | $-18.3M | $53.0M | ||
| Q3 24 | $2.3M | $16.3M | ||
| Q2 24 | $-3.1M | $14.0M | ||
| Q1 24 | $-4.7M | $6.8M |
| Q4 25 | 9.1% | 47.1% | ||
| Q3 25 | 22.9% | 22.4% | ||
| Q2 25 | -1.5% | 4.0% | ||
| Q1 25 | 40.8% | 5.3% | ||
| Q4 24 | -27.4% | 73.2% | ||
| Q3 24 | 4.8% | 20.8% | ||
| Q2 24 | -6.3% | 17.8% | ||
| Q1 24 | -13.6% | 8.6% |
| Q4 25 | 0.4% | 10.4% | ||
| Q3 25 | 0.3% | 1.8% | ||
| Q2 25 | 0.3% | 2.2% | ||
| Q1 25 | 0.4% | 2.3% | ||
| Q4 24 | 0.8% | 9.1% | ||
| Q3 24 | 1.2% | 1.7% | ||
| Q2 24 | 0.7% | 2.4% | ||
| Q1 24 | 0.3% | 3.3% |
| Q4 25 | 1.27× | 28.39× | ||
| Q3 25 | 16.26× | 4.45× | ||
| Q2 25 | -0.16× | 0.97× | ||
| Q1 25 | — | — | ||
| Q4 24 | -2.62× | 10.28× | ||
| Q3 24 | — | 18.22× | ||
| Q2 24 | — | 4.29× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HROW
Segment breakdown not available.
RMAX
| Franchising Segment | $50.1M | 70% |
| Broker Fees | $13.9M | 20% |
| Annual Dues | $7.4M | 10% |
